In The Hill today, reporter Elise Viebeck reports from the recent American Society of Clinical Oncology meeting about the increasing number of new cancer medicines reaching the Food and Drug Administration
Most Recent Posts
Today we have guest post from cancer survivor Susan Parkinson, who talks about her battle with Non-Hodgkin's Lymphoma (NHL).
Cancer poses a major public health challenge for us as individuals, our economy and our society as a whole. Over the next several days, we will be devoting a page on our website to cancer week: Medicines in Development for Cancer.
National Cancer Survivors Day is Sunday, June 3. It is an annual celebration of life to show the world that there is life after a cancer diagnosis. And I, Jeff Trewhitt, am a proud cancer survivor. Here's a look at my life after cancer.
Unfortunately, today most of us know someone that has had to battle cancer. On the bright side, more and more people are winning that fight. We've come a long way since signs of cancer were found in the bones of mummies from ancient Egypt, to declaring war on cancer, to approving vaccines for cancer.
The Los Angeles Times recently ran a provoking story on insurance company coverage of specialty medicines and the increasing share of the cost patient
The 2012 Pharmaceutical Industry Profile is now available as a free interactive e-book on the popular iTunes Bookstore.
This year, one of the key topics of conversation at our annual meeting was the importance of collaboration among different members of the research ecosystem - and rightly so, as this collaboration
Today the U.S. Chamber of Commerce released a study that shows the importance of intellectual property to jobs in every state.